| [1] |
Yin L,Wang Y,Chen S,et al.Advances of glucagon-like peptide-1 receptor agonists in the treatment of nervous system diseases[J].J China Pharm Univ(中国药科大学学报),2014,45(4):383-391.
|
| [2] |
Li CY,Huang WL,Qian H.Advances in the research of long-acting strategy of insulin and GLP-1 analogs[J].J China Pharm Univ(中国药科大学学报),2018,49(6):660-670.
|
| [3] |
Guglielmi V,Sbraccia P.GLP-1 receptor independent pathways:emerging beneficial effects of GLP-1 breakdown products[J].Eat Weight Disord,2017,22(2):231-240.
|
| [4] |
Wang Y, Egan JM, Raygada M, et al. Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells[J].Endocrinology,1995,136(11):4910-4917.
|
| [5] |
Huang YY,Xu MX,Zhuang PW,et al.Advances on the Epac signal molecule in cardiovascular diseases[J].Chin J New Drugs(中国新药杂志),2017,26(17):2034-2039.
|
| [6] |
Oh YS,Jun HS.Effects of glucagon-like peptide-1 on oxidative stress and Nrf2 signaling[J].Int J Mol Sci,2017,19(1):E26.
|
| [7] |
Palus K,Caka J.Diabetes mellitus in cats relevant to human type 2 diabetes-current knowledge and new treatment strategies-a review[J].Ann Anim Sci Vol,2015,15(1):19-30.
|
| [8] |
Hölscher C.Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide analogues as novel treatments for Alzheimer′s and Parkinson′s disease[J].Cardiovasc Endocrinol,2016,5(3):93-98.
|
| [9] |
Rajappa R,Sireesh D,Salai MB,et al.Treatment with naringenin elevates the activity of transcription factor Nrf2 to protect pancreatic β-cells from streptozotocin-induced diabetes in vitro and in vivo[J].Front Pharmacol,2019,9:1562.
|
| [10] |
Li S,Vaziri ND,Masuda Y,et al.Pharmacological activation of Nrf2 pathway improves pancreatic islet isolation and transplantation[J].Cell Transplant,2015,24(11):2273-2283.
|
| [11] |
Puddu A,Mach F,Nencioni A,et al.An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes[J].Mediators Inflamm,2013,2013:591056.
|
| [12] |
Fernández-Millán E,Martín MA,Goya L,et al.Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation[J].Free Radic Biol Med,2016,95:16-26.
|
| [13] |
Oh YS,Seo E,Park K,et al.Compound 19e,a novel glucokinase activator,protects against cytokine-induced beta-cell apoptosis in INS-1 cells[J].Front Pharmacol,2017,8:169.
|
| [14] |
Tomas E,Stanojevic V,Habener JF.GLP-1-derived nonapeptide GLP-1(28-36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes[J].Regul Pept,2011,167(2/3):177-184.
|
| [15] |
Kim MH,Kim EH,Jung HS,et al.EX4 stabilizes and activates Nrf2 via PKCδ,contributing to the prevention of oxidative stress-induced pancreatic beta cell damage[J].Toxicol Appl Pharmacol,2017,315:60-69.
|
| [16] |
Bunck MC,Cornér A,Eliasson B,et al.One-year treatment with exenatide vs.insulin glargine:effects on postprandial glycemia,lipid profiles,and oxidative stress[J].Atherosclerosis,2010,212(1):223-229.
|
| [17] |
Okada K,Kotani K,Yagyu H,et al.Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus[J].Endocrine,2014,47(3):962-964.
|
| [18] |
Rizzo M,Abate N,Chandalia M,et al.Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes:a prospective pilot study[J].J Clin Endocrinol Metab,2015,100(2):603-606.
|
| [19] |
Wu YL,Huang J,Liu J,et al.Protective effect of recombinant human glucagon-like peptide-1(rhGLP-1)pretreatment in STZ-induced diabetic mice[J].J Pept Sci,2011,17(7):499-504.
|
| [20] |
Shimoda M,Kanda Y,Hamamoto S,et al.The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes[J].Diabetologia,2011,54(5):1098-1108.
|
| [21] |
Ding XK,Saxena NK,Lin SB,et al.Exendin-4,a glucagon-like protein-1(GLP-1)receptor agonist,reverses hepatic steatosis in ob/ob mice[J].Hepatology,2006,43(1):173-181.
|
| [22] |
Patel V,Joharapurkar A,Dhanesha N,et al.Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice[J].Pharmacol Rep,2013,65(4):927-936.
|
| [23] |
Mangmool S,Hemplueksa P,Parichatikanond W,et al.Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes[J].Mol Endocrinol,2015,29(4):583-596.
|
| [24] |
Li Q,Lin Y,Wang S,et al.GLP-1 inhibits high-glucose-induced oxidative injury of vascular endothelial cells[J].Sci Rep,2017,7(1):8008.
|
| [25] |
Civantos E,Bosch E,Ramirez E,et al.Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway[J].Diabetes Metab Syndr Obes,2017,10:207-222.
|
| [26] |
Wei J,Zhang Y,Luo Y,et al.Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2,Tgfβ1/2,and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice[J].Free Radic Biol Med,2014,67:91-102.
|
| [27] |
Fujita H,Morii T,Fujishima H,et al.The protective roles of GLP-1R signaling in diabetic nephropathy:possible mechanism and therapeutic potential[J].Kidney Int,2014,85(3):579-589.
|
| [28] |
Hendarto H,Inoguchi T,Maeda Y,et al.GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases[J].Metab Clin Exp,2012,61(10):1422-1434.
|
| [29] |
Teramoto S,Miyamoto N,Yatomi K,et al.Exendin-4,a glucagon-like peptide-1 receptor agonist,provides neuroprotection in mice transient focal cerebral ischemia[J].J Cereb Blood Flow Metab,2011,31(8):1696-1705.
|
| [30] |
Chien CT, Jou MJ, Cheng TY, et al. Exendin-4-loaded PLGA microspheres relieve cerebral ischemia/reperfusion injury and neurologic deficits through long-lasting bioactivity-mediated phosphorylated Akt/eNOS signaling in rats[J].J Cereb Blood Flow Metab,2015,35(11):1790-1803.
|
| [31] |
Zhu HL,Zhang YS,Shi ZS,et al.The neuroprotection of liraglutide against ischaemia-induced apoptosis through the activation of the PI3K/AKT and MAPK pathways[J].Sci Rep,2016,6:26859.
|
百度学术
下载:
